RCMI Coordinating Center (RCMI CC) Header Logo

Sheilah Clayton

Concepts (48)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Nurse's Role
1
2011
31
0.400
 Why?
Breast Neoplasms
5
2017
1502
0.380
 Why?
Clinical Trials as Topic
1
2011
204
0.360
 Why?
Health Services Accessibility
1
2011
560
0.290
 Why?
Minority Groups
1
2011
596
0.280
 Why?
Receptor, erbB-2
2
2017
133
0.200
 Why?
Transforming Growth Factor beta
1
2017
197
0.130
 Why?
Survivors
1
2014
136
0.110
 Why?
Nurse-Patient Relations
1
2011
5
0.100
 Why?
Academic Medical Centers
1
2011
60
0.100
 Why?
Patient Participation
1
2011
75
0.090
 Why?
Patient Selection
1
2011
164
0.090
 Why?
California
1
2011
476
0.090
 Why?
Amino Acid Transport Systems
1
2006
5
0.070
 Why?
Paclitaxel
1
2006
50
0.070
 Why?
Amino Acids
1
2006
145
0.070
 Why?
Proto-Oncogene Proteins c-akt
1
2008
269
0.070
 Why?
Antineoplastic Agents, Phytogenic
1
2006
110
0.060
 Why?
Female
5
2017
20969
0.050
 Why?
Apoptosis
1
2006
1398
0.040
 Why?
Humans
5
2017
37093
0.040
 Why?
Thiosemicarbazones
1
2017
10
0.040
 Why?
Receptors, Transforming Growth Factor beta
1
2017
24
0.040
 Why?
beta Catenin
1
2017
48
0.040
 Why?
Pyrazoles
1
2017
85
0.040
 Why?
Vascular Endothelial Growth Factor A
1
2017
161
0.030
 Why?
Cell Line, Tumor
2
2017
2231
0.030
 Why?
Drug Resistance, Neoplasm
1
2017
222
0.030
 Why?
Evidence-Based Medicine
1
2014
97
0.030
 Why?
Data Collection
1
2014
194
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2017
807
0.020
 Why?
Disease-Free Survival
1
2008
113
0.020
 Why?
Ethylmaleimide
1
2006
9
0.020
 Why?
Starvation
1
2006
12
0.020
 Why?
Maleimides
1
2006
13
0.020
 Why?
Alanine
1
2006
30
0.020
 Why?
Survival Analysis
1
2008
325
0.020
 Why?
In Situ Nick-End Labeling
1
2006
133
0.020
 Why?
Antibiotics, Antineoplastic
1
2006
44
0.020
 Why?
Sodium
1
2006
103
0.020
 Why?
Caspases
1
2006
147
0.020
 Why?
Doxorubicin
1
2006
84
0.020
 Why?
Immunohistochemistry
1
2008
893
0.020
 Why?
Enzyme Inhibitors
1
2006
433
0.020
 Why?
Dose-Response Relationship, Drug
1
2006
1039
0.010
 Why?
Gene Expression Regulation
1
2006
1015
0.010
 Why?
Cell Proliferation
1
2006
1198
0.010
 Why?
Middle Aged
1
2008
10129
0.010
 Why?
Clayton's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (48)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support